These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5065155)

  • 1. [Anti-staphylococcal activities of mitomycin derivatives and its relationship to antileukemic effects].
    Kojima R
    Igaku To Seibutsugaku; 1972 Jan; 84(1):27-32. PubMed ID: 5065155
    [No Abstract]   [Full Text] [Related]  

  • 2. Some structive-activity relationships for mitomycin C (NSC-26980) derivatives in the treatment of L1210 leukemia.
    Kojima R; Driscoll J; Mantel N; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):121-35. PubMed ID: 4660731
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and antitumor and antibacterial activity of benzoquinones related to the mitomycins.
    Witty TR; Remers WA
    J Med Chem; 1973 Nov; 16(11):1280-4. PubMed ID: 4201183
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationships of the mitomycins and certain synthetic analogs.
    Remers WA; Schepman CS
    J Med Chem; 1974 Jul; 17(7):729-32. PubMed ID: 4151967
    [No Abstract]   [Full Text] [Related]  

  • 5. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
    Sartorelli AC; Booth BA
    Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
    [No Abstract]   [Full Text] [Related]  

  • 6. Nucleotide derivatives of 2,7-diaminomitosene.
    Iyengar BS; Dorr RT; Remers WA; Kowal CD
    J Med Chem; 1988 Aug; 31(8):1579-85. PubMed ID: 3397995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of schedule of administration of mitomycin C (NSC-26980) in the treatment of L1210 leukemia.
    Kojima R; Goldin A; Mantel N
    Cancer Chemother Rep 2; 1972 Nov; 3(1):111-9. PubMed ID: 4660730
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.
    Hodges JC; Remers WA; Bradner WT
    J Med Chem; 1981 Oct; 24(10):1184-91. PubMed ID: 7328580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-automated structure evaluation of antileukemic 9-anilinoacridines.
    Klopman G; Macina OT
    Mol Pharmacol; 1987 Apr; 31(4):457-76. PubMed ID: 3574291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of long-term human leukocyte cell cultures as models for the study of antileukemic agents.
    Hirshaut Y; Weiss GH; Perry S
    Cancer Res; 1969 Sep; 29(9):1732-40. PubMed ID: 5258874
    [No Abstract]   [Full Text] [Related]  

  • 11. Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia.
    Iyengar BS; Dorr RT; Remers WA
    J Med Chem; 1991 Jul; 34(7):1947-51. PubMed ID: 1906107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters.
    Koutsourea AI; Fousteris MA; Arsenou ES; Papageorgiou A; Pairas GN; Nikolaropoulos SS
    Bioorg Med Chem; 2008 May; 16(9):5207-15. PubMed ID: 18353651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of novel, aminoalkanolic derivatives of 5,7-dihydroxy-2-phenylbenzopyran-4-on as the potential cytostatic agents.
    Mazur A; Balicka E; Zawadowski T; Miks B; Kawiak J
    Mater Med Pol; 1995; 27(4):157-9. PubMed ID: 9000841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileukemic and cytogenetic effects of modified and non-modified esteric steroidal derivatives of 4-methyl-3-bis(2-chloroethyl)amino benzoic acid (4-Me-CABA).
    Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelato D; Nikolaropoulos SS
    Anticancer Res; 2002; 22(4):2293-9. PubMed ID: 12174917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileukemic effects of 5-(2-dimethylaminoethoxy)-7-oxo-7H-benzo(c) fluorene, substance VUFB 13 468, on L1210 and La leukemia.
    Pujman V; Cernochová S
    Neoplasma; 1981; 28(6):715-20. PubMed ID: 7339500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of N4-spermidine derivatives and their potential in anticancer chemotherapy.
    Porter CW; Bergeron RJ; Stolowich NJ
    Cancer Res; 1982 Oct; 42(10):4072-8. PubMed ID: 7105005
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
    Venditti JM; Sheldon DR; Goldin A
    Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
    Iyengar BS; Sami SM; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1983 Jan; 26(1):16-20. PubMed ID: 6827524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-antileukemic activity relationship study of B- and D-ring modified and nonmodified steroidal esters of 4-methyl-3-N,N-bis(2-chloroethyl)amino benzoic acid: a comparative study.
    Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelatos D; Nikolaropoulos SS
    Anticancer Drugs; 2007 Oct; 18(9):997-1004. PubMed ID: 17704649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.